Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Sep 29, 2023 8:23am
241 Views
Post# 35661152

RE:RE:New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)

RE:RE:New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)Yes this is aimed at potential partners and finally we may be past the monthly/quarterly news releases.

I get the feeling that when they mentioned they had submitted the pre-BTD that THEY got the feeling that BTD was just a matter of when not if because these news releases are all about the future of Ruvidar.

I can't wait for THAT news release!


99942Apophis wrote:

Very impressive,  reading between the lines to me is if we begin to see NRs every few weeks then it is a build up to the bigger NRs we are expecting. Todays news in my mind is huge in the fact I don't think any other Biopharmaceutical company has a product that can remain potent anywhere close to Ruvidar, please correct me if I'm wrong. 
Once again Theralase amazes me!


<< Previous
Bullboard Posts
Next >>